Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedApr 3, 2024HYDROmorphone HCl 20 mg/100mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0404-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0403-2024Class IITerminatedApr 3, 2024fentaNYL 1Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0402-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0401-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0400-2024Class IITerminatedApr 3, 2024fentaNYL 100 mcg/50 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0399-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0398-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0397-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0396-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0395-2024Class IITerminatedApr 3, 2024Diltiazem HCl 125 mg in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0394-2024Class ITerminatedMar 27, 2024Neptune's FixMarketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.Super Chill Products · D-0393-2024Class IIOngoingMar 27, 2024InfumorphThe filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.Hikma Pharmaceuticals USA Inc. · D-0392-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0391-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0390-2024Class IIITerminatedMar 27, 2024Digoxin TabletsCross Contamination with Other Products:(mycophenolate mofetil).Novitium Pharma LLC · D-0389-2024Class IITerminatedMar 20, 2024Telmisartan TabletsFailed Stability Specifications: Out of specification for blend uniformity.Micro Labs Limited · D-0388-2024Class IIOngoingMar 20, 2024Broncochem Cold & TeaStability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or...Global Corporation · D-0387-2024Class IIOngoingMar 20, 2024Broncochem Cold & Flu Syrup KidsStability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or...Global Corporation · D-0386-2024Class IITerminatedMar 20, 2024Tobramycin for InjectionFailed Stability Specification: Water determination was found not complying with specification.Eugia US LLC · D-0385-2024Class IIOngoingMar 20, 2024hyalogic For Dry EyesLack of Assurance of SterilityOptikem International, Inc. · D-0384-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Red Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0383-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Pink Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0382-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Aging Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0381-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Floaters ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0380-2024Class IIOngoingMar 20, 2024TRP Eye strain ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0379-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Dryness ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0378-2024Class IIOngoingMar 20, 2024TRP Eye Twitching ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0377-2024Class IIOngoingMar 20, 2024TRP Blur ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0376-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Allergy Eyes ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0375-2024Class IITerminatedMar 20, 2024BetimolLack of Assurance of Sterility: Out of specification for volume and compromised container closure.Thea Pharma, Inc. · D-0374-2024Class IITerminatedMar 20, 2024Bicillin L-AcGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0373-2024Class IITerminatedMar 20, 2024Infuvite Adult Multiple vitamins injectioncGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0372-2024Class IITerminatedMar 20, 2024Rocuronium Bromide InjectioncGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0371-2024Class IITerminatedMar 20, 2024Potassium Chloride for Injection Concentrate USPLack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.B. Braun Medical Inc · D-0370-2024Class IIOngoingMar 20, 2024Febuxostat Tablets 80mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0369-2024Class IIOngoingMar 20, 2024Febuxostat Tablets 40mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0368-2024Class IIITerminatedMar 13, 2024Mercaptopurine TabletsFailed Dissolution Specifications: results slightly under spec at at 9-months.Stason Pharmaceuticals, Inc. · D-0367-2024Class IIOngoingMar 13, 2024Methylprednisolone acetate Injectable SuspensionFailed Dissolution SpecificationsEugia US LLC · D-0366-2024Class IIIOngoingMar 13, 2024Clindamycin Phosphate Topical Solution USPDefective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.Contract Pharmaceuticals Limited Canada · D-0365-2024

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.